• Multiple Myeloma

Michael Rosenzweig, M.D., M.S., joined City of Hope in 2011, as a staff physician and associate professor in the Department of Hematology & Hematopoietic Cell Transplantation. Dr. Rosenzweig received his bachelor's in psychology from Emory University and went on to earn a Master of Science in physiology and biophysics from Georgetown University, Washington, D.C. He attended the University of Arizona College of Medicine for his medical degree. He completed his residency in internal medicine and a fellowship in hematology/oncology at Boston Medical Center, during which he was appointed chief fellow. From 2009 to 2011, Dr. Rosenzweig was a fellow in bone marrow transplantation at Memorial Sloan Kettering Cancer Center in New York, New York.

As a hematologist and member of the plasma cell disease team, Dr. Rosenzweig has a clinical focus on multiple myeloma and related diseases, including Waldenstrom macroglobulinemia, POEMs syndrome and light chain amyloidosis.

Dr. Rosenzweig enjoys caring for a multitude of patients with multiple myeloma at all stages of the disease process and actively participates in clinical research exploring new treatments. He has a particular interest in smoldering myeloma, a precursor condition to active disease, and is actively involved in research exploring new treatments to prevent disease progression.

As the director of the amyloidosis program at City of Hope, he greatly enjoys caring for patients with all forms of amyloidosis, including light chain (AL), a disease closely related to multiple myeloma, as well as transthyretin (TTR), secondary amyloidosis (AA) and LECT2. 

He works closely with a multidisciplinary team, including cardiology, nephrology and neurology, to care for patients with amyloidosis. His research interests include finding new treatments for amyloidosis at various stages of the disease process.